Picture of Bionano Genomics logo

BNGO — Bionano Genomics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bionano Reports Fourth Quarter And Full-Year 2023 Results

March 5 (Reuters) - Bionano Genomics Inc  BNGO.O :
    * BIONANO REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
AND
PROVIDES REVENUE OUTLOOK FOR 2024
    * BIONANO GENOMICS INC: SINCE MAY 2023 THROUGH COMPLETION OF
INITIATIVE ANNOUNCED TODAY, WE AIM TO HAVE REDUCED HEADCOUNT BY
APPROXIMATELY 200 PEOPLE
    * BIONANO GENOMICS INC: REDUCED ANNUALIZED OPERATING
EXPENSES BY
ABOUT $65.0 TO $75.0 MILLION
    * BIONANO GENOMICS INC:  WITH 2024 COST SAVINGS INITIATIVE,
WILL
BE REDUCING ANNUALIZED OPERATING EXPENSE BY ANOTHER ESTIMATED
$35.0 TO $40.0 MILLION
    * BIONANO: INITIATIVE INCLUDES POTENTIAL REDUCTION IN
HEADCOUNT BY
AN ADDITIONAL 110 TO 125 EMPLOYEES

Source text for Eikon:  ID:nGNX7wrRXq 
Further company coverage:  BNGO.O

Recent news on Bionano Genomics

See all news